Elevance Health — Apr 17, 2025 release

In addition, the Company continues to expect full-year 2025 Medicare Advantage membership of 2,200 to 2,250 thousand members, in line with the guidance provided in its Fourth Quarter 2024 Earnings Release, dated January 23, 2025. Based on these results and the Company’s outlook, the Company intends to reaffirm shareholders’ adjusted net income guidance for full year 2025 to be $34.15 to $34.85 per diluted share. The Company will provide additional details on its first quarter financial results and full year outlook when it reports results on April 22, 2025. None of the information furnished in Item 2.02 and Item 7.01 hereto shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings. FORWARD-LOOKING STATEMENTS     This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan” and similar expressions are intended to identify forward-looking statements. These statements include, but are not lim